StockData
Aclarion, Inc. logo

Aclarion, Inc. (ACONW) stock

ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 8/30
$0.02+0.00 (0.00%)

Close on Oct 30, 2026Market cap $5.62MP/E –Yield –

Aclarion shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Aclarion's shares outstanding was 2M at Jun 30, 2026. For fiscal 2025 it was 1M, up 56319.5% from the year before. The highest annual figure on record is 1M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+56319.5%
FY2024Dec 31, 20240M+1421.0%
FY2023Dec 31, 20230M+47.6%
FY2022Dec 31, 20220M+600.0%
FY2021Dec 31, 20210M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20262M+322.8%
Q1 FY2026Mar 31, 20262M+870.9%
Q4 FY2025Dec 31, 20251M+60943.6%
Q3 FY2025Sep 30, 20251M+55736.1%
Q2 FY2025Jun 30, 20251M+64037.8%
Q1 FY2025Mar 31, 20250M+36339.5%
Q4 FY2024Dec 31, 20240M+1483.1%
Q3 FY2024Sep 30, 20240M+1667.8%
Q2 FY2024Jun 30, 20240M+1493.0%
Q1 FY2024Mar 31, 20240M+994.5%
Q4 FY2023Dec 31, 20230M+42.6%
Q3 FY2023Sep 30, 20230M+9.3%
Q2 FY2023Jun 30, 20230M+850.0%
Q1 FY2023Mar 31, 20230M+816.7%
Q4 FY2022Dec 31, 20220M–
Q3 FY2022Sep 30, 20220M–
Q4 FY2021Dec 31, 20210M–
Q3 FY2021Sep 30, 20210M–

More Aclarion figures